CA Stock MarketDetailed Quotes
NOVA Nova Mentis Life Science Corp
- 0.015
- 0.0000.00%
15min DelayTrading Jul 22 10:02 ET
2.22MMarket Cap-750P/E (TTM)
0.000High0.000Low0Volume0.000Open0.015Pre Close0.00Turnover0.03552wk High0.00%Turnover Ratio148.32MShares0.01052wk Low-0.02EPS TTM1.99MFloat Cap122.880Historical HighLossP/E (Static)132.36MShs Float0.010Historical Low-0.02EPS LYR0.00%Amplitude--Dividend TTM-2.50P/B1Lot Size--Div YieldTTM
Nova Mentis Life Science Corp Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 73.05%-46.27K | 69.98%-171.68K | 25.82%-1.44M | 62.77%-203.83K | 54.67%-172.41K | -27.42%-495.45K | 9.15%-571.93K | -127.22%-1.95M | -29.55%-547.49K | -164.83%-380.33K |
| Net income from continuing operations | 72.66%-144.38K | 15.78%-528.01K | 8.15%-2.47M | -338.91%-1.07M | 71.28%-402.94K | 12.87%-366.79K | -1.63%-626.93K | 89.36%-2.68M | 98.65%-243.61K | -153.05%-1.4M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -194.14%-24.35K | 14.25%-126.88K | ---- |
| Depreciation and amortization | -21.36%578 | -22.47%735 | -24.13%3.79K | -24.16%948 | -24.10%948 | -53.60%948 | 107.89%948 | -26.72%5K | -26.69%1.25K | -26.74%1.25K |
| Asset impairment expenditure | ---- | ---- | 13,963.55%764.78K | ---- | ---- | ---- | ---- | -99.90%5.44K | ---- | ---- |
| Remuneration paid in stock | --0 | 62.78%273.38K | -5.74%328.45K | -84.36%2.63K | -55.51%138.2K | 583.71%19.68K | 827.04%167.94K | -61.03%348.44K | -97.10%16.79K | --310.66K |
| Other non cashItems | ---- | 327.38%80K | 68.00%-72.32K | 123.95%53.04K | ---52.68K | -835.06%-37.5K | -6,297.09%-35.18K | -101.27%-225.99K | -101.93%-221.43K | --0 |
| Change In working capital | 4,301.35%97.53K | 102.82%2.22K | -100.39%-2.43K | 109.97%44K | -76.32%144.06K | -458.15%-111.8K | -156.59%-78.7K | 2,456.77%629.89K | -55.50%20.96K | 1,755.74%608.39K |
| -Change in receivables | 63.62%-501 | 94.83%-1.38K | 218.07%62.46K | 121.58%4.31K | 696.26%81.35K | 138.05%3.44K | -160.27%-26.64K | -479.38%-52.9K | -165.56%-19.99K | -493.85%-13.64K |
| -Change in prepaid assets | 105.47%4.62K | -558.51%-84.42K | -91.92%30.64K | -86.78%1.42K | -99.22%2.04K | 876,800.00%8.77K | -82.93%18.41K | 1,774.91%378.99K | -11.87%10.75K | --260.37K |
| -Change in payables and accrued expense | 6.14%93.42K | 224.89%88.01K | -131.45%-95.53K | 26.72%38.27K | -83.22%60.68K | -408.11%-124K | 45.08%-70.48K | 34,343.08%303.79K | -15.77%30.2K | 1,188.44%361.66K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 73.05%-46.27K | 69.98%-171.68K | 25.82%-1.44M | 62.77%-203.83K | 54.67%-172.41K | -27.42%-495.45K | 9.15%-571.93K | -127.22%-1.95M | -29.55%-547.49K | -164.83%-380.33K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -98.98%29.64K | -100.04%-965 | 138.04%26.04K | ||||||
| Net investment purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -95.96%29.64K | -100.11%-965 | 146.39%26.04K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -98.98%29.64K | -100.04%-965 | 161.82%26.04K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 214.14%60K | -98.71%19.1K | 1.49M | 8.4K | 0 | 0 | 1.48M | 0 | 0 | 0 |
| Net issuance payments of debt | --60K | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | ---- | ---- | --1.48M | --0 | --0 | --0 | --1.48M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | --19.1K | --8.4K | --8.4K | ---- | ---- | --0 | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 214.14%60K | -98.71%19.1K | --1.49M | --8.4K | --0 | --0 | --1.48M | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -96.97%8.09K | 21.85%266.52K | -89.76%218.73K | -39.79%461.95K | -43.44%634.36K | -24.97%1.13M | -89.76%218.73K | 2,354.22%2.14M | 164.61%767.18K | 135.77%1.12M |
| Current changes in cash | 109.00%13.73K | -116.75%-152.58K | 102.49%47.79K | 64.37%-195.43K | 51.34%-172.41K | -28.93%-495.45K | 244.72%911.07K | -193.57%-1.92M | -129.72%-548.45K | -90.74%-354.28K |
| End cash Position | -80.85%21.82K | -89.92%113.94K | 21.85%266.52K | 21.85%266.52K | -39.79%461.95K | -43.44%634.36K | -24.97%1.13M | -89.76%218.73K | -89.76%218.73K | 164.61%767.18K |
| Free cash from | 73.05%-46.27K | 69.98%-171.68K | 25.82%-1.44M | 62.77%-203.83K | 54.67%-172.41K | -27.42%-495.45K | 9.15%-571.93K | -127.22%-1.95M | -29.55%-547.49K | -164.83%-380.33K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg